Comparative investigation of the safety of hexavalent vaccines for primary scheduled infant immunizations in Germany over a time period of 2 years

Medical Science Monitor

Volumn 10, Issue 9, 2004, Pages

  Lackmann, Gerd M ^a,b  

^a Outpatient Paediatric Office   (Germany)

^b NONE   (Germany)

Author keywords

Safety of polyvalent vaccines; Side effects; Trivalent vaccines; Vaccine associated complications

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEXAVALENT DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B RECOMBINANT HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; TETANUS TOXOID; TRIPLE VACCINE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIPHTHERIA; EDEMA; ERYTHEMA; FEVER; FOLLOW UP; GERMANY; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; INJECTION SITE; MAJOR CLINICAL STUDY; PERTUSSIS; PILOT STUDY; POLIOMYELITIS; PRESCHOOL CHILD; SAFETY; TETANUS;

GERMANY; HUMANS; INFANT; PILOT PROJECTS; VACCINES, COMBINED;

EID: 4644224575     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Black RE, Morris SS, Bryce J: Where and why are 10 million children dying every year? Lancet, 2003; 361: 2226-34
2. Andre FE: Vaccinology: Past achievement, present roadblocks and future promises. Vaccine, 2003; 21: 593-95
3. CDC: Update: Global measles control and mortality reduction - worldwide, 2001. Morb Mortal Wkly Rep, 2003; 52: 471-75
4. Bogaerts H: The future of childhood immunizations: Examining the European experience. Am J Manag Care, 2003; 9(Suppl. 1): S30-36
5. Avdicova M, Prikazsky V, Hudeckova H et al: Immunogenicity and reactogenicity of a novel hexavalent DT-HBV-IPV/HiB vaccine compared to separate concomitant injections of DTPa-IPV/HiB and HBV vaccines, when administered to a 3,5 and 11 month vaccination schedule. Eur J Pediatr, 2002; 161: 581-87
6. FitzSimons D, Francois G, Emiroglu N, Van Damme P: Combined hepatitis B vaccines. Vaccine, 2003; 21: 1310-16
7. Deutsche Akademie für Kinderheilkunde und Jugendmedizin. Kommission für Infektionskrankheiten und Impffragen: Stellungnahme zur Sicherheit von hexavalenten Kombinationsimpfstoffen. Monatsschr Kinderheilkd, 2003; 151: 788
8. Forth W et al: (eds.) Allgemeine und Spezielle Pharmakologie und Toxikologie. 8. Aufl, Urban & Fischer Verlag, 2001; 533